ArticleGeriatrics & gerontology international2026
Durable Response to Durvalumab in Occult Small-Cell Lung Cancer With Immune Checkpoint Inhibitor-Related Inflammatory Arthritis With Polymyalgia Rheumatica-Like Features.
Akihito Fujimi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.